Literature DB >> 18316424

Anxious depression and response to treatment.

J Craig Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316424     DOI: 10.1176/appi.ajp.2007.07121927

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

1.  Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study.

Authors:  Simon J C Davies; Benoit H Mulsant; Alastair J Flint; Anthony J Rothschild; Ellen M Whyte; Barnett S Meyers
Journal:  Compr Psychiatry       Date:  2014-02-12       Impact factor: 3.735

2.  Heart rate variability as a biomarker of anxious depression response to antidepressant medication.

Authors:  Katharina Kircanski; Leanne M Williams; Ian H Gotlib
Journal:  Depress Anxiety       Date:  2018-10-12       Impact factor: 6.505

Review 3.  Anxious depression: clinical features and treatment.

Authors:  Sanjai Rao; Sidney Zisook
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

4.  Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.

Authors:  M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler
Journal:  Psychol Med       Date:  2008-12-02       Impact factor: 7.723

5.  "Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

Authors:  Koen Demyttenaere; Anne Verhaeghen; Nicolas Dantchev; Luigi Grassi; Angel L Montejo; David G S Perahia; Deborah Quail; Catherine Reed; Andre Tylee; Michael Bauer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

6.  A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders.

Authors:  Sang Won Jeon; Changsu Han; Young-Hoon Ko; Seoyoung Yoon; Chi-Un Pae; Joonho Choi; Jae-Min Kim; Ho-Kyoung Yoon; Hoseon Lee; Ashwin A Patkar; Mark Zimmerman
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

7.  Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study.

Authors:  Kristin Köhler-Forsberg; Brice Ozenne; Søren V Larsen; Asbjørn S Poulsen; Elizabeth B Landman; Vibeke H Dam; Cheng-Teng Ip; Anders Jørgensen; Claus Svarer; Gitte M Knudsen; Vibe G Frokjaer; Martin B Jørgensen
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

8.  Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study.

Authors:  George I Papakostas; Maurizio Fava; Marlene P Freeman; Richard C Shelton; Michael E Thase; Manish K Jha; Madhukar H Trivedi; Bryan Dirks; Keith Liu; Srdjan Stankovic
Journal:  Int Clin Psychopharmacol       Date:  2020-11       Impact factor: 2.023

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.